The fundamentals of the company haven't changed.
The cash position is strong (fully funded)
The drug clearly works, mountains of evidence, with a strong safety history.
Competent experienced management.
Massive future potential revenues with both application (OA, MPS).
The last few months is just the market doing its thing, no need for an exit plan IMO.
- Forums
- ASX - By Stock
- PAR
- Where is the green?
Where is the green?, page-135
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.55M |
Open | High | Low | Value | Volume |
21.0¢ | 22.0¢ | 20.5¢ | $222.5K | 1.035M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 77810 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 23000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 27810 | 0.210 |
3 | 47926 | 0.205 |
9 | 245349 | 0.200 |
8 | 278635 | 0.195 |
15 | 183884 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 13000 | 1 |
0.225 | 72722 | 5 |
0.230 | 31334 | 3 |
0.235 | 45854 | 2 |
0.240 | 65386 | 4 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |